{
    "applicationNumber": "BR 11 2022 009942-8",
    "filingDate": "23/11/2020",
    "grantDate": null,
    "title": "DERIVADOS DE 1,2,4-OXADIAZOL COMO AGONISTAS DO RECEPTOR X DO F\u00cdGADO",
    "nationalPhaseDate": [
        "20/05/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT IB2020/061053",
        "pctDate": "23/11/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/940,061",
            "priorityDate": "25/11/2019"
        },
        {
            "countryCode": "US",
            "priorityNumber": "63/106,293",
            "priorityDate": "27/10/2020"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2682"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2692"
        }
    ],
    "inventors": [
        "KELLY D BOSS",
        "YI FAN",
        "ALEC NATHANSON FLYER",
        "DECLAN HARDY",
        "ZHIHONG HUANG",
        "KATHRYN TAYLOR LINKENS",
        "JON CHRISTOPHER LOREN",
        "FUPENG MA",
        "VALENTINA MOLTENI",
        "DUNCAN SHAW",
        "JEFFREY SMITH",
        "CATHERINE FOOKS SOLOVAY"
    ],
    "holders": [
        79188
    ],
    "ipcCodes": [
        "C07D 413/06",
        "A61K 31/42",
        "A61P 27/00"
    ]
}